HbA1c Blood Test: Normal Range, High Levels, Prediabetes, Diabetes & Laboratory Interpretation (2026)
Last Updated: August 19, 2026
The HbA1c blood test, also known as the A1C test, hemoglobin A1C, glycated hemoglobin, or glycohemoglobin, is one of the most widely used laboratory tests for assessing long-term glycemic status. Unlike a single plasma glucose measurement, HbA1c reflects average glucose exposure over approximately the previous 2–3 months.
HbA1c is used for screening and diagnosis of prediabetes and type 2 diabetes and for monitoring glycemic control in people with established diabetes. Interpretation, however, requires an understanding of red blood cell lifespan, hemoglobin variants, analytical methodology, and clinical circumstances that may produce misleading results.
Table of Contents
- What Is HbA1c?
- How HbA1c Is Formed
- What Does HbA1c Measure?
- HbA1c Normal Range
- HbA1c Levels Chart
- HbA1c and Prediabetes
- HbA1c and Diabetes
- High HbA1c Levels
- Low HbA1c Levels
- HbA1c and Estimated Average Glucose
- HbA1c vs Fasting Glucose
- HbA1c vs OGTT
- Sample Requirements
- Laboratory Methods
- HPLC
- Immunoassay
- Enzymatic Methods
- HbA1c Interferences
- HbA1c and Anemia
- Hemoglobin Variants
- Blood Transfusion and HbA1c
- Kidney Disease and HbA1c
- HbA1c in Pregnancy
- HbA1c Quality Control
- Laboratory Troubleshooting
- Clinical Case Studies
- Frequently Asked Questions
- Authoritative References
1. What Is the HbA1c Blood Test?
HbA1c is a form of hemoglobin that has glucose attached to it. Because circulating erythrocytes remain in the bloodstream for several months, the amount of glycated hemoglobin provides an integrated estimate of glucose exposure rather than a single-time-point measurement.
The test has an important advantage over fasting plasma glucose because the patient generally does not need to fast before sample collection. This makes HbA1c convenient for both screening and long-term monitoring.
Because HbA1c depends partly on erythrocyte survival, it should be interpreted alongside hematological findings when results appear discordant. A complete blood count (CBC) can provide important information about hemoglobin concentration, erythrocyte indices, and other abnormalities that may influence interpretation.
2. How Is HbA1c Formed?
Hemoglobin A is the major hemoglobin fraction in most adults. Glucose circulating in blood enters red blood cells and binds nonenzymatically to hemoglobin.
The degree of glycation is related to the concentration of glucose to which the red blood cell is exposed. Persistent hyperglycemia therefore results in a larger proportion of glycated hemoglobin.
Because the process is influenced by erythrocyte survival, any disorder that changes the average age of circulating red blood cells may change HbA1c independently of the patient's actual glucose concentration.
3. What Does HbA1c Measure?
HbA1c is reported primarily as a percentage in NGSP units. Laboratories may also report results in IFCC units as mmol/mol.
A higher HbA1c generally indicates higher average blood glucose during the preceding weeks and months. However, HbA1c should not automatically be interpreted as an exact mathematical average for every patient because biological and analytical factors can produce discordance.
4. HbA1c Normal Range
| Classification | HbA1c (%) | IFCC (mmol/mol) |
|---|---|---|
| Normal / below prediabetes threshold | <5.7% | <39 |
| Prediabetes | 5.7–6.4% | 39–47 |
| Diabetes diagnostic threshold | ≥6.5% | ≥48 |
These diagnostic thresholds apply to nonpregnant individuals. In the absence of unequivocal hyperglycemia, an abnormal result used to diagnose diabetes generally requires confirmation with a second abnormal result.
5. HbA1c Levels Chart
| HbA1c | General Interpretation |
|---|---|
| 4.0–5.6% | Below the prediabetes diagnostic threshold |
| 5.7–6.4% | Prediabetes range |
| ≥6.5% | Meets the HbA1c laboratory threshold for diabetes |
6. HbA1c and Prediabetes
An HbA1c between 5.7% and 6.4% is classified as prediabetes in nonpregnant individuals. Prediabetes represents an intermediate glycemic state and is associated with increased risk of developing type 2 diabetes.
Risk is not identical throughout this interval. In general, individuals toward the upper end of the prediabetes range have a greater risk of progression than those with values near 5.7%.
7. What Does HbA1c ≥6.5% Mean?
An HbA1c result of 6.5% (48 mmol/mol) or higher meets the laboratory criterion for diabetes when an appropriate standardized laboratory method is used.
A single HbA1c result should not automatically be treated as a confirmed diagnosis in an asymptomatic individual. In the absence of unequivocal hyperglycemia, diagnostic confirmation generally requires two abnormal results, either from the same test at different time points or from two appropriate diagnostic tests.
8. High HbA1c Levels: Causes
Common reasons for elevated HbA1c include:
- Persistent hyperglycemia
- Poorly controlled diabetes mellitus
- Insufficient medication or insulin effect
- Medication nonadherence
- Dietary patterns contributing to persistent hyperglycemia
- Reduced physical activity
- Progressive insulin resistance
- Intercurrent illness or physiological stress
- Certain medications that increase blood glucose
Importantly, an unexpectedly high HbA1c should be compared with plasma glucose or glucose-monitoring data. Discordance can suggest altered erythrocyte turnover, hemoglobin interference, or another analytical or biological factor.
9. Low HbA1c Levels
A low HbA1c can reflect genuinely low average glucose, but laboratory professionals should also consider conditions that shorten red blood cell survival.
- Hemolytic anemia
- Recent significant blood loss
- Increased erythrocyte turnover
- Recent transfusion
- Certain hemoglobinopathies
- Other clinical conditions associated with shortened RBC lifespan
When erythrocytes survive for less time than expected, they have less time to become glycated, potentially producing a falsely low HbA1c relative to the patient's true glycemic exposure.
When anemia is suspected, review low hemoglobin, MCV, MCH and RDW interpretation together with the broader laboratory approach to anemia.
10. HbA1c and Estimated Average Glucose (eAG)
Estimated average glucose translates HbA1c into units that resemble routine glucose measurements.
eAG (mg/dL) = 28.7 × HbA1c − 46.7
| HbA1c | Approximate eAG (mg/dL) |
|---|---|
| 5% | 97 |
| 6% | 126 |
| 7% | 154 |
| 8% | 183 |
| 9% | 212 |
| 10% | 240 |
eAG is an estimate and should not be interpreted as though glucose remained at that concentration continuously.
11. HbA1c vs Fasting Plasma Glucose
| Feature | HbA1c | Fasting Plasma Glucose |
|---|---|---|
| Fasting required | No | Yes |
| Reflects | Longer-term glycemic exposure | Glucose concentration at collection |
| Diabetes threshold | ≥6.5% | ≥126 mg/dL (7.0 mmol/L) |
12. HbA1c vs Oral Glucose Tolerance Test
The 75-g oral glucose tolerance test evaluates the body's response to a standardized glucose load. A two-hour plasma glucose value of 200 mg/dL (11.1 mmol/L) or higher meets the diagnostic threshold for diabetes in nonpregnant individuals.
HbA1c is more convenient because fasting and a two-hour sampling period are not required, but HbA1c and OGTT do not necessarily identify exactly the same individuals.
13. HbA1c Sample Requirements
- Specimen: anticoagulated whole blood
- Common collection tube: EDTA whole blood
- Fasting: not required
- Patient preparation: generally no special preparation
Exact specimen stability, acceptable anticoagulants, storage temperatures, and transport requirements should always follow the validated laboratory procedure and manufacturer's instructions for the specific analytical system.
Preanalytical quality remains important in every laboratory workflow. For an example of specimen-related analytical interference, see the complete guide to hemolysis in clinical chemistry.
14. Laboratory Methods for HbA1c Measurement
Major analytical principles include:
- Ion-exchange high-performance liquid chromatography (HPLC)
- Boronate affinity chromatography
- Immunoassay
- Enzymatic assays
- Capillary electrophoresis
For diagnostic use, laboratories should use appropriately standardized methods. NGSP certification links HbA1c results to the reference established through the Diabetes Control and Complications Trial.
15. HPLC for HbA1c Measurement
Ion-exchange HPLC separates hemoglobin fractions according to differences in charge. The analyzer generates a chromatogram from which HbA1c and other fractions can be identified or quantified according to the system's analytical design.
Advantages
- High precision on validated systems
- Automated quantitative analysis
- Chromatogram review may reveal abnormal patterns
- Some systems can flag potential hemoglobin variants
Important Limitation
HPLC should not simply be described as universally superior to every other HbA1c method. Performance and susceptibility to interference depend on the specific assay, instrument, hemoglobin variant, and validation characteristics.
16. HbA1c Immunoassay
Immunoassays use antibodies directed against glycated regions of hemoglobin. They can provide rapid and automated measurement and are available on several clinical chemistry platforms.
The effect of hemoglobin variants differs by method, so laboratories should review the manufacturer's interference data and current NGSP information for the assay in use.
17. Enzymatic HbA1c Methods
Enzymatic methods use specific biochemical reactions to quantify glycated hemoglobin. They can be integrated into automated chemistry workflows and may provide excellent analytical performance when appropriately calibrated and standardized.
18. Factors That Can Interfere With HbA1c
An HbA1c result may become misleading because of either analytical interference or altered red blood cell biology.
| Factor | Possible Effect | Interpretive Consideration |
|---|---|---|
| Hemolysis / shortened RBC survival | May falsely lower HbA1c | Reduced erythrocyte lifespan decreases time available for glycation |
| Recent major blood loss | May lower HbA1c | Changes mean erythrocyte age |
| Hemoglobin variants | Method-dependent | Review assay-specific interference data |
| Elevated HbF | Method-dependent | May interfere with some methods |
| Recent transfusion | Unpredictable / difficult to interpret | Patient and donor erythrocytes contribute to measured HbA1c |
| Altered erythropoiesis | Potentially misleading | Interpret with CBC and clinical context |
19. HbA1c and Anemia
Anemia is one of the most important considerations when HbA1c does not match glucose results.
Conditions associated with shortened erythrocyte survival, such as hemolytic anemia, can produce falsely low HbA1c values. Other anemia states may influence HbA1c through different mechanisms, so the underlying cause of anemia should be considered rather than interpreting all anemia identically.
Iron status may also be clinically relevant when evaluating anemia. For related laboratory interpretation, see high ferritin levels and laboratory interpretation.
20. Hemoglobin Variants and HbA1c
Hemoglobin variants such as HbS, HbC, HbE, and HbD can interfere with some HbA1c assays. The direction and magnitude of interference depend on the specific analytical method.
When HbA1c is inconsistent with the patient's glucose results, the laboratory should consider whether a hemoglobin variant or elevated fetal hemoglobin may be present and review the interference characteristics of the assay in use.
21. Blood Transfusion and HbA1c
Recent red blood cell transfusion can make HbA1c difficult to interpret because the measured sample contains erythrocytes originating from different individuals with different ages and previous glucose exposure.
Clinical teams should therefore interpret post-transfusion HbA1c cautiously and consider alternative measures of glycemia when appropriate.
For additional transfusion laboratory context, see the ABO blood group system, forward and reverse grouping, and ABO discrepancies.
22. Kidney Disease and HbA1c
Advanced kidney disease can complicate HbA1c interpretation because anemia, altered red blood cell survival, treatment affecting erythropoiesis, transfusion, and other factors may change the relationship between HbA1c and actual glucose exposure.
When renal dysfunction is suspected, laboratory assessment may include serum creatinine and estimated glomerular filtration rate. See high creatinine, eGFR, BUN and kidney-function interpretation.
Routine urine testing may provide additional clinical information in appropriate patients. For laboratory methodology and interpretation, see the complete urinalysis guide.
23. HbA1c in Pregnancy
Pregnancy requires separate diagnostic considerations. The standard HbA1c thresholds presented for nonpregnant adults should not simply be applied as a stand-alone method for diagnosing gestational diabetes.
Pregnant patients should be evaluated according to pregnancy-specific clinical guidelines and glucose-testing protocols.
24. HbA1c Quality Control in the Laboratory
Reliable HbA1c testing requires a comprehensive quality management process. Laboratories should follow manufacturer instructions, validated procedures, applicable regulatory requirements, and their own quality control policies.
Internal Quality Control
- Run appropriate control materials at defined intervals.
- Review QC results before reporting patient results.
- Use Levey–Jennings charts when incorporated into the laboratory QC system.
- Evaluate shifts and trends.
- Investigate QC failures before releasing affected patient results.
- Document corrective actions.
For a detailed explanation of QC interpretation, review Internal Quality Control, Westgard Rules and Levey–Jennings charts.
External Quality Assessment
Participation in proficiency testing or external quality assessment allows a laboratory to compare performance with appropriate peer groups or assigned targets and identify potential systematic analytical problems.
Broader laboratory performance should also be monitored using defined quality indicators. See Laboratory Quality Indicators, KPIs and ISO 15189 quality management.
25. Laboratory Troubleshooting: Unexpected HbA1c Results
If an HbA1c result appears inconsistent with the clinical picture:
- Verify patient and specimen identification.
- Review specimen acceptability.
- Confirm QC status.
- Review calibration and analyzer status when relevant.
- Check for instrument flags or abnormal chromatogram patterns.
- Compare the result with previous HbA1c values.
- Compare HbA1c with available glucose results.
- Consider anemia, hemolysis, blood loss, or transfusion.
- Consider hemoglobin variants or elevated HbF.
- Repeat or investigate using an appropriate alternative method when indicated.
- Document the investigation according to laboratory policy.
When inflammation, infection, or systemic illness may contribute to a patient's clinical picture, complementary testing may include markers such as C-reactive protein (CRP) or, in appropriate clinical settings, procalcitonin (PCT).
26. HbA1c Clinical Case Studies
Case 1: Prediabetes
A patient undergoing routine screening has an HbA1c of 6.1%. This falls within the 5.7–6.4% prediabetes range.
The result indicates increased risk of progression to type 2 diabetes and should be interpreted with the patient's clinical risk factors and other metabolic findings.
Case 2: HbA1c Meets the Diabetes Threshold
An asymptomatic patient has an HbA1c of 6.8%. This meets the laboratory threshold for diabetes.
Because there is no unequivocal hyperglycemia, confirmation with a second abnormal diagnostic result is generally required.
Case 3: HbA1c Does Not Match Glucose
A patient's HbA1c is unexpectedly low despite repeatedly elevated glucose results. The CBC demonstrates anemia and further investigation suggests increased red cell turnover.
The laboratory should recognize that shortened erythrocyte survival can falsely lower HbA1c and communicate relevant interpretive information according to local laboratory policy.
Case 4: HbA1c Discordance in Kidney Disease
A patient with advanced kidney dysfunction has glucose measurements suggesting persistent hyperglycemia, while HbA1c appears unexpectedly low.
The laboratory should review anemia, erythrocyte turnover, erythropoiesis-modifying therapy, transfusion history, renal status, and analytical factors before assuming that HbA1c accurately represents the patient's glycemic exposure.
Case 5: Possible Hemoglobin Variant
An HbA1c chromatogram shows an unexpected peak and the reported HbA1c is inconsistent with the patient's glucose measurements.
The laboratory should review analyzer flags, chromatographic pattern, assay limitations and the possibility of a hemoglobin variant before releasing or clinically interpreting an unreliable result.
27. Frequently Asked Questions
What is a normal HbA1c?
For diagnostic classification in nonpregnant individuals, an HbA1c below 5.7% is below the prediabetes threshold.
What HbA1c indicates prediabetes?
An HbA1c of 5.7–6.4% is classified as prediabetes in nonpregnant individuals.
What HbA1c indicates diabetes?
An HbA1c of 6.5% or higher meets the diagnostic laboratory threshold for diabetes. Confirmatory testing is generally required when unequivocal hyperglycemia is absent.
Do I need to fast for an HbA1c test?
No. Fasting is generally not required for HbA1c measurement.
Can anemia affect HbA1c?
Yes. Conditions that alter erythrocyte lifespan can change HbA1c independently of glucose exposure.
Can hemoglobin variants affect HbA1c?
Yes. HbS, HbC, HbE, HbD and elevated HbF may interfere with some methods, and the effect is assay dependent.
Can recent blood transfusion affect HbA1c?
Yes. Recent transfusion may make HbA1c difficult to interpret reliably because donor and recipient erythrocytes contribute to the result.
Why does HbA1c not match my glucose results?
Possible explanations include changes in red blood cell lifespan, anemia, hemoglobin variants, transfusion, analytical interference, or differences between longer-term glycemic exposure and individual glucose measurements.
What causes a high HbA1c?
A high HbA1c most commonly reflects persistent hyperglycemia. However, results should be interpreted with glucose data and relevant biological or analytical factors when the value is unexpected.
Can kidney disease affect HbA1c results?
Yes. Advanced kidney disease may complicate HbA1c interpretation through anemia, altered erythrocyte lifespan, transfusion and therapies that affect erythropoiesis.
28. Authoritative References
- American Diabetes Association Professional Practice Committee – Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) – The A1C Test & Diabetes
- NIDDK – Diabetes Tests & Diagnosis
- NGSP – HbA1c Standardization Program
- NGSP – HbA1c Assay Interferences
- NGSP – Factors That Interfere With HbA1c Test Results
- NGSP – IFCC Standardization of HbA1c
- MedlinePlus – Hemoglobin A1C (HbA1c) Test
Prepared by MedLab Academy
Laboratory Medicine Education & Clinical Interpretation
.jpg)